These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Normalization of 14-3-3 in CJD. Schrooten M; De Vooght W; Weckhuysen S; Van Paesschen W; Van Damme P Acta Neurol Belg; 2008 Jun; 108(2):64-6. PubMed ID: 18795599 [TBL] [Abstract][Full Text] [Related]
47. Interleukin 4 and interleukin 10 in Creutzfeldt-Jakob disease. Iwasaki Y; Baba S; Ikeda K Arch Neurol; 2006 Jun; 63(6):911; author reply 911. PubMed ID: 16769878 [No Abstract] [Full Text] [Related]
48. Atypical presentation of probable Creutzfeldt-Jakob disease associated with anti-Zic4 antibody: Literature review of neuronal antibodies in Creutzfeldt-Jakob disease. Salazar R Clin Neurol Neurosurg; 2018 May; 168():72-76. PubMed ID: 29525731 [TBL] [Abstract][Full Text] [Related]
49. Increased levels of epsilon and gamma isoforms of 14-3-3 proteins in cerebrospinal fluid in patients with Creutzfeldt-Jakob disease. Takahashi H; Iwata T; Kitagawa Y; Takahashi RH; Sato Y; Wakabayashi H; Takashima M; Kido H; Nagashima K; Kenney K; Gibbs CJ; Kurata T Clin Diagn Lab Immunol; 1999 Nov; 6(6):983-5. PubMed ID: 10548598 [TBL] [Abstract][Full Text] [Related]
50. [Creutzfeldt-Jakob disease: Report of one case]. Ramírez M; Gallardo A; Vidal A; Cornejo S; Ramírez D; Medinas D; Bustamante G; Pasquali R; Hetz C Rev Med Chil; 2016 Jun; 144(6):796-806. PubMed ID: 27598501 [TBL] [Abstract][Full Text] [Related]
52. Creutzfeldt-Jakob Disease. Le VH J Am Osteopath Assoc; 2019 Jan; 119(1):63. PubMed ID: 30615045 [No Abstract] [Full Text] [Related]
53. Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease. Green AJ; Knight RS; Macleod MA; Lowman A; Will RG Neurology; 2001 Apr; 56(7):986-7. PubMed ID: 11294951 [No Abstract] [Full Text] [Related]
54. Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease. Green AJ Biochem Soc Trans; 2002 Aug; 30(4):382-6. PubMed ID: 12196099 [TBL] [Abstract][Full Text] [Related]
55. Clinical and laboratory features of 14 young Chinese probable sCJD patients. Shi Q; Xiao K; Chen C; Zhou W; Gao C; Wang J; Zhang BY; Wang Y; Dong XP Prion; 2017 Mar; 11(2):128-135. PubMed ID: 28278113 [TBL] [Abstract][Full Text] [Related]
56. Diagnostic value of CSF 14-3-3 detection in sporadic CJD diagnosis according to the age of the patient. Peoc'h K; Delasnerie-Lauprêtre N; Beaudry P; Laplanche JL Eur J Neurol; 2006 Apr; 13(4):427-8. PubMed ID: 16643327 [No Abstract] [Full Text] [Related]
57. Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease. Aksamit AJ; Preissner CM; Homburger HA Neurology; 2001 Aug; 57(4):728-30. PubMed ID: 11524493 [TBL] [Abstract][Full Text] [Related]